Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e516-e517. doi: 10.1111/jdv.18059. Epub 2022 Mar 15.

Authors

C Ben Salem¹, A Khelif², D Sahnoun¹, N Ghariani², B Sriha³, M Denguezli²

Affiliations

¹ Clinical Pharmacology, Pharmacovigilance Center of Sousse, University of Sousse, Sousse, Tunisia.
² Dermatology, Farhat Hached Hospital, University of Sousse, Sousse, Tunisia.
³ Pathology, Farhat Hached Hospital, University of Sousse, Sousse, Tunisia.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenoviridae
COVID-19* / prevention & control
ChAdOx1 nCoV-19* / adverse effects
Drug Eruptions* / etiology
Humans

Substances

ChAdOx1 nCoV-19